Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Nivolumab After Initial Treatment in Patients with Metastatic Triple-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Nivolumab and Cisplatin for Patients with Metastatic Triple Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria Czechia Denmark Finland France +8
  • Study on the Safety of ARV-471 and Everolimus for Patients with Advanced or Metastatic ER+, HER2- Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Spain
  • Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Denmark France Germany Italy The Netherlands +2
  • Study of BB-1701 for Patients with HER2-positive or HER2-low Metastatic Breast Cancer

    Not recruiting

    2 1 1
    France Germany Spain
  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated Drugs:
    Spain
  • Study of Abemaciclib and Tamoxifen in Women with Metastatic Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy